MECP2 and beyond: phenotype-genotype correlations in Rett syndrome

Area of Science:

• Genetics
• Neuroscience
• Developmental Biology

Background:

• Rett syndrome is a neurodevelopmental disorder associated with the methyl-CpG binding protein 2 (MECP2) gene.
• The clinical presentation of Rett syndrome is influenced by MECP2 mutation type, location, and epigenetic factors like X-chromosome inactivation skewing.

Purpose of the Study:

• To elucidate the pathogenesis of Rett syndrome.
• To explore the link between MECP2 mutations and various clinical phenotypes, including non-Rett syndrome presentations.
• To pave the way for developing targeted therapies.

Main Methods:

• Analysis of MECP2 gene mutations.
• Investigation of epigenetic factors, including X-chromosome inactivation.
• Utilizing advanced techniques like microarray analysis.
• Development and study of mouse models.

Main Results:

• Established association between MECP2 mutations and Rett syndrome since 1999.
• Demonstrated that MECP2 mutation characteristics and epigenetic factors correlate with clinical phenotypes.
• Identified MECP2 mutations in other neurodevelopmental conditions like X-linked mental retardation and Angelman-like phenotypes.

Conclusions:

• MECP2 gene mutations are central to Rett syndrome pathogenesis.
• Understanding genotype-phenotype correlations and epigenetic influences is crucial for therapeutic development.
• Ongoing research aims to develop effective treatments for Rett syndrome and related disorders.